Multiple myeloma trials in Puerto Rico
7 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleCevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
- Where
- San Juan
- Age
- 18 years and over
- People
- 380 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07555938 · EU 2025-524028-23-00 - Phase 3Taking peopleA Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
- Where
- San Juan
- Age
- 18 years and over
- People
- 810 worldwide
- Run by
- Celgene
See details and how to joinNCT05519085 - Phase 3Taking peopleA Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
- Where
- San Juan
- Age
- 18 years and over
- People
- 1,060 worldwide
- Run by
- Pfizer
See details and how to joinNCT05623020 · EU 2024-514139-50-00 - Phase 2Taking peopleA Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
- Where
- San Juan
- Age
- 18 years and over
- People
- 210 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06500884 · EU 2023-506260-14-00 - Phase 2Taking peopleTAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Where
- Cayey, Dorado, Manati, Mayagüez, Ponce, San Juan
- Age
- 12 years and over
- People
- 4,200 worldwide
- Run by
- American Society of Clinical Oncology
See details and how to joinNCT02693535 - Phase 3Taking peopleLenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
- Where
- Bayamón, Caguas, Manati, San Juan
- Age
- 18 years and over
- People
- 288 worldwide
- Run by
- ECOG-ACRIN Cancer Research Group
See details and how to joinNCT03937635 - Phase 3Taking peopleTesting the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
- Where
- Bayamón, Manati, San Juan
- Age
- 18 years and over
- People
- 1,450 worldwide
- Run by
- ECOG-ACRIN Cancer Research Group
See details and how to joinNCT04566328